Literature DB >> 11330949

Tumor distribution and survival in six patients with brain metastases from cervical carcinoma.

A S Mahmoud-Ahmed1, J H Suh, G H Barnett, K D Webster, A W Kennedy.   

Abstract

OBJECTIVE: The aim of this study was to investigate the patterns of brain involvement and the outcome of patients with brain metastases from cervical carcinoma.
METHODS: Between January 1982 and November 1999, 1279 patients with brain metastases were treated at the Cleveland Clinic. Six of them had brain metastases from cervical carcinoma. We retrospectively reviewed the patient and tumor characteristics at the time of the primary diagnosis as well as at the time of the brain metastases diagnosis.
RESULTS: Brain metastases from cervical carcinoma were rarely accompanied by systemic disease, but they were commonly accompanied by uncontrolled local-regional disease. The median interval from the appearance of the primary carcinoma to the detection of brain metastases in 5 patients was 12 months. Multiple brain lesions developed in 4 of 6 patients and consisted of multiple tumors distributed in the cerebral hemispheres (2 patients) or both the cerebral and the cerebellar hemispheres (2 patients). Only 2 patients had a single lesion confined to a cerebral hemisphere. One patient was treated with stereotactic radiosurgery alone, 3 with surgery followed by whole brain radiation therapy, 1 with whole brain radiotherapy, and 1 each with whole brain radiotherapy and stereotactic radiosurgery. Patients treated with surgery had a median survival of 8.25 months, while patients treated with whole brain radiotherapy with or without stereotactic radiosurgery had a median survival of 3.75 months. The 1 patient treated with stereotactic radiosurgery alone survived for 22.5 months.
CONCLUSION: Although the number of the patients was too small to detect definitive patterns of brain metastases from cervical carcinoma, the results of our review suggest that, in contrast to previous reports, extended survival can occur with more aggressive treatment such as surgery or stereotactic radiosurgery. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11330949     DOI: 10.1006/gyno.2001.6140

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  Stereotactic radiosurgical treatment of brain metastasis of primary tumors that rarely metastasize to the central nervous system.

Authors:  Joshua Y Menendez; David F Bauer; Chevis N Shannon; John Fiveash; James M Markert
Journal:  J Neurooncol       Date:  2012-07-03       Impact factor: 4.130

Review 2.  Single brain metastases from cervical carcinoma: report of two cases and critical review of the literature.

Authors:  A Marongiu; M Salvati; A D'Elia; A Arcella; F Giangaspero; V Esposito
Journal:  Neurol Sci       Date:  2011-11-24       Impact factor: 3.307

3.  Stereotactic radiosurgery as a therapeutic strategy for intracranial metastatic prostate carcinoma.

Authors:  Thomas Flannery; Hideyuki Kano; Ajay Niranjan; Edward A Monaco; John C Flickinger; L Dade Lunsford; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2009-07-17       Impact factor: 4.130

4.  Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Authors:  Laura M Divine; Nora T Kizer; Andrea R Hagemann; Meredith E Pittman; Ling Chen; Matthew A Powell; David G Mutch; Janet S Rader; Premal H Thaker
Journal:  Gynecol Oncol       Date:  2016-05-08       Impact factor: 5.482

Review 5.  Advances in diagnosis and treatment of metastatic cervical cancer.

Authors:  Haoran Li; Xiaohua Wu; Xi Cheng
Journal:  J Gynecol Oncol       Date:  2016-07       Impact factor: 4.401

Review 6.  Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review.

Authors:  Neville F Hacker; Archana Rao
Journal:  Gynecol Oncol Res Pract       Date:  2016-06-17

7.  A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.

Authors:  Nakamasa Hayashi; Hideaki Takahashi; Yuzo Hasegawa; Fumi Higuchi; Masamichi Takahashi; Keishi Makino; Masatoshi Takagaki; Jiro Akimoto; Takeshi Okuda; Yoshiko Okita; Koichi Mitsuya; Yasuyuki Hirashima; Yoshitaka Narita; Yoko Nakasu
Journal:  BMC Cancer       Date:  2017-06-02       Impact factor: 4.430

Review 8.  Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature.

Authors:  Gregory M Gressel; Lisbet S Lundsberg; Gary Altwerger; Tasleem Katchi; Masoud Azodi; Peter E Schwartz; Elena S Ratner; Shari Damast
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

9.  Parkinsonism in a recurrent cervical cancer patient: case report and review of the literature.

Authors:  Afshin Azimirad; Zahra Sarraf
Journal:  J Family Reprod Health       Date:  2013-12

Review 10.  Cervical cancer metastasis to the brain: A case report and review of literature.

Authors:  Kaleigh Fetcko; Dibson D Gondim; Jose M Bonnin; Mahua Dey
Journal:  Surg Neurol Int       Date:  2017-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.